相似文献
1
Illicit organogenesis: Methods and substances of doping and manipulation.
Organogenesis. 2008 Oct;4(4):264-71. doi: 10.4161/org.4.4.7286.
2
Detection of SARMs in doping control analysis.
Mol Cell Endocrinol. 2018 Mar 15;464:34-45. doi: 10.1016/j.mce.2017.01.040. Epub 2017 Jan 27.
3
Emerging drugs: mechanism of action, mass spectrometry and doping control analysis.
J Mass Spectrom. 2009 Apr;44(4):442-60. doi: 10.1002/jms.1584.
4
Mass spectrometric characterization of the hypoxia-inducible factor (HIF) stabilizer drug candidate BAY 85-3934 (molidustat) and its glucuronidated metabolite BAY-348, and their implementation into routine doping controls.
Drug Test Anal. 2017 Jan;9(1):61-67. doi: 10.1002/dta.2011. Epub 2016 Jun 27.
5
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.
J Pharm Biomed Anal. 2014 Dec;101:66-83. doi: 10.1016/j.jpba.2014.05.020. Epub 2014 May 23.
6
Mass spectrometric studies on selective androgen receptor modulators (SARMs) using electron ionization and electrospray ionization/collision-induced dissociation.
Eur J Mass Spectrom (Chichester). 2018 Feb;24(1):145-156. doi: 10.1177/1469066717731228. Epub 2017 Sep 13.
7
Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
Rapid Commun Mass Spectrom. 2011 Aug 15;25(15):2187-95. doi: 10.1002/rcm.5100.
8
Emerging drugs--potential for misuse in sport and doping control detection strategies.
Mini Rev Med Chem. 2007 May;7(5):531-7. doi: 10.2174/138955707780619590.
9
Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
Drug Test Anal. 2015 Aug;7(8):673-83. doi: 10.1002/dta.1768. Epub 2015 Jan 5.
10
Detection of the arylpropionamide-derived selective androgen receptor modulator (SARM) S-4 (Andarine) in a black-market product.
Drug Test Anal. 2009 Aug;1(8):387-92. doi: 10.1002/dta.91.
引用本文的文献
1
'Blood doping' from Armstrong to prehabilitation: manipulation of blood to improve performance in athletes and physiological reserve in patients.
Extrem Physiol Med. 2016 Feb 29;5:5. doi: 10.1186/s13728-016-0046-0. eCollection 2016.
2
The androgen receptor and its use in biological assays: looking toward effect-based testing and its applications.
J Anal Toxicol. 2011 Nov;35(9):594-607. doi: 10.1093/anatox/35.9.594.
本文引用的文献
1
Doping control analysis of tricyclic tetrahydroquinoline-derived selective androgen receptor modulators using liquid chromatography/electrospray ionization tandem mass spectrometry.
Rapid Commun Mass Spectrom. 2008 Aug;22(16):2471-8. doi: 10.1002/rcm.3637.
2
Mass spectrometry of selective androgen receptor modulators.
J Mass Spectrom. 2008 Jul;43(7):865-76. doi: 10.1002/jms.1438.
3
Growth hormone, IGF-I and insulin and their abuse in sport.
Br J Pharmacol. 2008 Jun;154(3):542-56. doi: 10.1038/bjp.2008.99. Epub 2008 Mar 31.
4
Determination of benzimidazole- and bicyclic hydantoin-derived selective androgen receptor antagonists and agonists in human urine using LC-MS/MS.
Anal Bioanal Chem. 2008 May;391(1):251-61. doi: 10.1007/s00216-008-1882-6. Epub 2008 Feb 13.
5
Remodeling of ryanodine receptor complex causes "leaky" channels: a molecular mechanism for decreased exercise capacity.
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2198-202. doi: 10.1073/pnas.0711074105. Epub 2008 Feb 11.
6
Stressed out: the skeletal muscle ryanodine receptor as a target of stress.
J Clin Invest. 2008 Feb;118(2):445-53. doi: 10.1172/JCI34006.
7
Mass spectrometry of hydantoin-derived selective androgen receptor modulators.
J Mass Spectrom. 2008 May;43(5):639-50. doi: 10.1002/jms.1364.
8
Gas phase reaction of substituted isoquinolines to carboxylic acids in ion trap and triple quadrupole mass spectrometers after electrospray ionization and collision-induced dissociation.
J Am Soc Mass Spectrom. 2008 Jan;19(1):151-8. doi: 10.1016/j.jasms.2007.11.003. Epub 2007 Nov 9.
9
Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
Int J Sports Med. 2008 Jan;29(1):1-6. doi: 10.1055/s-2007-989369. Epub 2007 Nov 30.
10
Mass spectrometric determination of insulins and their degradation products in sports drug testing.
Mass Spectrom Rev. 2008 Jan-Feb;27(1):35-50. doi: 10.1002/mas.20154.
Zotero 插件